Financials
- Market Capitalization 3.15 B
- Employee 61
- Founded 2016
- CEO N/A
- Website www.enliventherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00CP3BDD4
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-8.42
市销率
-8 232.35
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1665 | BEAM Beam Therapeutics Inc. - Common Stock | 30.89 USD | -0.35% | -15.21% | -0.74% | +56.33% | 3.18 B USD | ||
| 1672 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 32.03 USD | -3.58% | -9.11% | +25.41% | +16.94% | 3.15 B USD | ||
| 1686 | VERA Vera Therapeutics, Inc. - Class A Common Stock | 43.13 USD | +3.93% | +0.30% | +25.05% | +45.02% | 3.10 B USD | ||
| 1710 | CLDX Celldex Therapeutics, Inc. - Common Stock | 38.17 USD | -0.93% | -3.37% | +20.37% | +40.12% | 3.00 B USD |